About
NGL Fine-Chem Limited develops and manufactures veterinary APIs, human APIs, intermediates, and finished dosage forms in India, Europe, the Asia Pacific, the United States, and internationally. The company offers afoxolaner, amitraz, atovaquone, buparvaquone, butaphosphan, carprofen, clorsulon, closantel base, closantel sodium, decoquinate, diminazene diaceturate, febantel, fenbendazole, fluazuron, flumethrin, flunixin meglumine, fluralaner, halquinol, homidium chloride, imidocarb dipropionate, isometamidium chlroide HCl, lotilaner, marbofloxacin, maropitant citrate monohydrate, nitroscanate, nitroxynil, oclacitinib maleate, oxfendazole, parvaquone, permethrin, phenazone, ponazuril, praziquantel, ractopamine HCL, rafoxanide, ricobendazole, r-praziquantel, sarolaner, s-methoprene, toldimfos sodium, toltrazuril, triclabendazole, xylazine base, xylazine HCl, and zilpaterol. It also provides anthelmintics, antiprotozoals, ectoparasiticides, phosphorus supplements, coccidiostats, and non-steroidal anti-inflammatory drugs. In addition, the company offers atovaquone, nitazoxanide, and praziquantel for anti malarial, anti diarrheal, and anthelmintic therapeutic categories. Further, it provides specialty chemicals, such as meglumine, n-ethyl-d-glucamine, n-octyl-d-glucamine, 1,4,7-trimethyl-1,4,7-triazonane, and Mn-MeTACN. It serves companies engages in manufacturing custom pharmaceuticals. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139.00 | 149.00 | 128.00 | 120.00 | 104.00 | 95.00 | 89.00 | 93.00 | 91.00 | 100.00 | 88.00 | 80.00 | 71.00 |
| Expenses | 116.00 | 128.00 | 105.00 | 103.00 | 93.00 | 89.00 | 84.00 | 82.00 | 81.00 | 84.00 | 74.00 | 66.00 | 61.00 |
| Operating Profit | 23.00 | 21.00 | 22.00 | 17.00 | 11.00 | 6.00 | 5.00 | 12.00 | 9.00 | 16.00 | 14.00 | 14.00 | 10.00 |
| OPM % | 17.00 | 14.00 | 18.00 | 14.00 | 11.00 | 7.00 | 6.00 | 12.00 | 10.00 | 16.00 | 16.00 | 17.00 | 14.00 |
| Other Income | 7.00 | 2.00 | 5.00 | 2.00 | 6.00 | -1.00 | 0.00 | 5.00 | 6.00 | 4.00 | 4.00 | 3.00 | 3.00 |
| Depreciation | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Interest | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 24.00 | 18.00 | 21.00 | 13.00 | 12.00 | 1.00 | 1.00 | 13.00 | 12.00 | 16.00 | 14.00 | 14.00 | 10.00 |
| Tax % | 25.00 | 24.00 | 24.00 | 26.00 | 22.00 | 49.00 | -1.00 | 26.00 | 22.00 | 23.00 | 30.00 | 25.00 | 16.00 |
| Net Profit | 18.00 | 13.00 | 16.00 | 10.00 | 9.00 | 1.00 | 1.00 | 10.00 | 9.00 | 12.00 | 10.00 | 10.00 | 9.00 |
| EPS in Rs | 29.78 | 21.84 | 25.40 | 15.59 | 14.96 | 0.87 | 2.07 | 15.88 | 14.92 | 19.94 | 16.24 | 16.96 | 13.77 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 501.00 | 368.00 | 339.00 | 278.00 | 318.00 | 258.00 | 152.00 | 153.00 |
| Expenses | 421.00 | 333.00 | 285.00 | 243.00 | 249.00 | 178.00 | 130.00 | 121.00 |
| Operating Profit | 80.00 | 35.00 | 54.00 | 35.00 | 68.00 | 80.00 | 22.00 | 32.00 |
| OPM % | 16.00 | 10.00 | 16.00 | 13.00 | 21.00 | 31.00 | 14.00 | 21.00 |
| Other Income | 8.00 | 8.00 | 14.00 | 6.00 | 11.00 | 8.00 | 1.00 | 4.00 |
| Interest | 5.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 |
| Depreciation | 20.00 | 12.00 | 12.00 | 11.00 | 10.00 | 8.00 | 8.00 | 6.00 |
| Profit before tax | 63.00 | 28.00 | 54.00 | 27.00 | 67.00 | 78.00 | 12.00 | 28.00 |
| Tax % | 24.00 | 24.00 | 24.00 | 25.00 | 25.00 | 27.00 | 31.00 | 27.00 |
| Net Profit | 48.00 | 21.00 | 41.00 | 20.00 | 50.00 | 57.00 | 8.00 | 20.00 |
| EPS in Rs | 77.91 | 34.19 | 66.88 | 33.18 | 80.77 | 91.81 | 13.50 | 32.58 |
| Dividend Payout % | 2.00 | 5.00 | 3.00 | 5.00 | 2.00 | 2.00 | 13.00 | 5.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves | 326.00 | 279.00 | 260.00 | 219.00 | 200.00 | 151.00 | 96.00 | 89.00 |
| Borrowings | 123.00 | 78.00 | 34.00 | 32.00 | 30.00 | 16.00 | 28.00 | 27.00 |
| Other Liabilities | 94.00 | 75.00 | 59.00 | 32.00 | 44.00 | 36.00 | 26.00 | 23.00 |
| Total Liabilities | 545.00 | 435.00 | 356.00 | 287.00 | 277.00 | 207.00 | 154.00 | 142.00 |
| Fixed Assets | 164.00 | 143.00 | 86.00 | 88.00 | 89.00 | 64.00 | 68.00 | 61.00 |
| CWIP | 95.00 | 50.00 | 46.00 | 26.00 | 6.00 | 12.00 | 0.00 | 0.00 |
| Investments | 39.00 | 60.00 | 54.00 | 39.00 | 29.00 | 29.00 | 11.00 | 9.00 |
| Other Assets | 247.00 | 183.00 | 171.00 | 133.00 | 153.00 | 102.00 | 75.00 | 73.00 |
| Total Assets | 545.00 | 435.00 | 356.00 | 287.00 | 277.00 | 207.00 | 154.00 | 142.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 43.00 | 32.00 | 20.00 | 35.00 | 14.00 | 27.00 | 20.00 | 9.00 |
| Cash from Investing Activity | -71.00 | -70.00 | -27.00 | -27.00 | -14.00 | -25.00 | -20.00 | -10.00 |
| Cash from Financing Activity | 30.00 | 37.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | 0.00 |
| Net Cash Flow | 2.00 | 0.00 | -7.00 | 7.00 | -1.00 | 2.00 | 0.00 | -1.00 |
| Free Cash Flow | -43.00 | -41.00 | -8.00 | 5.00 | -15.00 | 10.00 | 6.00 | -6.00 |
| CFO/OP % | 73.00 | 111.00 | 62.00 | 121.00 | 45.00 | 60.00 | 110.00 | 50.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 95.00 | 82.00 | 97.00 | 86.00 | 74.00 | 53.00 | 63.00 | 79.00 |
| Inventory Days | 106.00 | 101.00 | 98.00 | 69.00 | 137.00 | 132.00 | 155.00 | 106.00 |
| Days Payable | 97.00 | 103.00 | 112.00 | 63.00 | 91.00 | 103.00 | 116.00 | 92.00 |
| Cash Conversion Cycle | 104.00 | 81.00 | 83.00 | 93.00 | 120.00 | 82.00 | 102.00 | 93.00 |
| Working Capital Days | 60.00 | 50.00 | 76.00 | 68.00 | 90.00 | 69.00 | 58.00 | 70.00 |
| ROCE % | 19.00 | 10.00 | 20.00 | 12.00 | 34.00 | 54.00 | 14.00 | — |
Corporate Actions
10 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 18 Aug 2026 | 18 Aug 2026 | — | 1.75 | |
| Dividend | 12 Aug 2025 | 12 Aug 2025 | — | 1.75 | |
| Dividend | 16 Aug 2024 | 16 Aug 2024 | — | 1.75 | |
| Dividend | 18 Aug 2023 | 18 Aug 2023 | — | 1.75 | |
| Dividend | 22 Jun 2022 | 23 Jun 2022 | — | 1.75 | |
| Dividend | 12 Aug 2021 | — | — | 1.75 | |
| Dividend | 06 Aug 2020 | 07 Aug 2020 | — | 1.75 | |
| Dividend | 13 Aug 2019 | — | — | 1.75 | |
| Dividend | 08 Aug 2007 | — | — | 0.50 | |
| Other | 17 Mar 2005 | 24 Mar 2005 | — | — | Scheme of Arrangement |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update30 Mar from icra
-
Rating update12 Mar from crisil
-
Rating update27 Jun 2025 from crisil
-
Rating update26 Jun 2025 from crisil
-
Rating update13 Mar 2025 from icra
-
Rating update1 Apr 2024 from icra